Weight management, no needle required.
A clinically supervised pathway built around oral GLP-1 tablets — the same proven biology behind weekly weight-management injections, in a once-daily tablet. No syringes, no fridge, no sharps bin.
Reviewed and prescribed by UK-regulated clinicians. Subject to consultation, supply, and prescribing guidance.
The same biology. Without the needle.
For years the most effective prescription weight-management treatments have arrived as a weekly injection. That works brilliantly for many patients — but for anyone who is needle-phobic, travels often, or just wants something simpler, the practical friction is real.
Oral GLP-1 tablets target the same appetite-regulating pathway as Wegovy and Mounjaro, but in a once-daily tablet you can keep in a kitchen cupboard rather than the fridge. Our medical team is preparing to add this option to our weight-management pathway as soon as supply and prescribing guidance allow.
Clinically studied formulations with published trial data behind their efficacy and safety profile.
Needle-free — a small daily tablet taken with water, no fridge storage, no sharps.
Reviewed, prescribed and monitored by UK-regulated clinicians as part of a full care pathway.
Designed around your day, not your fridge
A simple daily routine
Slot the tablet alongside your morning vitamins and you're done. No pens to refrigerate, no injection schedule to manage, no special handling when you travel.
Familiar mechanism, oral delivery
GLP-1 medicines work by quieting appetite, slowing how fast the stomach empties, and reducing the food-noise that makes calorie control hard. The oral formulations target the same pathway as injectable Wegovy and Mounjaro.
Clinical oversight, end to end
Every plan is reviewed by our medical team — initial assessment, dose progression, side-effect monitoring, and a clear pathway to adjust or pause treatment when needed.
A simple, supported path
Join the waitlist
Register your interest below — you'll be among the first to hear when prescribing opens.
Online assessment
A short clinical questionnaire reviewed by our team, plus any follow-up needed to confirm eligibility safely.
Personalised plan
If suitable, you receive a treatment plan that fits your goals, dose progression, and any other medication you're on.
Discreet delivery & support
Medication arrives in plain packaging. Our team stays in touch for monitoring, adjustments, and any questions along the way.
UK-regulated. Clinically led.
Every consultation is reviewed by qualified UK clinicians, and our pharmacy operates to GPhC standards. No black-box algorithms making prescribing decisions — every plan is signed off by a real person whose name is on the paperwork.
UK-regulated prescribers reviewing every consultation
Continuous monitoring throughout treatment
Specialist experience in medical weight management
Discreet delivery and confidential aftercare
What people are asking
How effective are oral GLP-1 tablets compared with injections?
Published trial data on oral semaglutide shows average weight loss in the region of 14–17% of body weight over the treatment course, while weekly injections such as Mounjaro can reach roughly 20% in similar populations. Individual results vary and depend on dose, adherence, and lifestyle.
Who is likely to be eligible?
Eligibility is decided at consultation. Broadly, GLP-1 weight management is considered for adults with a BMI of 30 or above, or 27.5+ with weight-related health conditions. Our clinicians will review your full medical history and any current medications before prescribing.
What does the daily routine look like?
Tablets are taken in the morning on an empty stomach with a small amount of water, then a wait before food or other tablets — exact timing depends on the molecule prescribed. We provide clear written guidance with your first delivery.
What about side effects?
The most common side effects mirror those of the injectable forms: mild nausea, reduced appetite, occasional digestive upset, particularly when stepping up the dose. Our team adjusts pace and dose to keep you comfortable, and you can pause treatment at any point.
When will it be available, and what will it cost?
Launch timing depends on UK supply and prescribing guidance. Waitlist members get the launch date, pricing and a priority consultation slot before public release.
Join the waitlist
Be first to hear when prescribing opens, with a priority consultation slot reserved before the public launch. We'll only email you about this treatment — nothing else, no spam.
This page is informational only and does not constitute medical advice. Treatments are subject to clinical assessment, supply, and UK prescribing guidance; eligibility is determined at consultation and results vary between individuals. Always consult a qualified healthcare professional before starting a new medication.